Categories: News

Indoco Remedies gains GMP Compliance Certificate for Goa plant


Goa February 17, 2014:- Indoco Remedies is a Pharmaceutical company engaged in manufacturing and marketing of drug products such as Anti-diabetics, Cardiovascular, Musculoskeletal, Nutrition, Central nervous System and dental care. The company operates in over 35 countries globally for Formulations and APIs. With approval of its Finished Dosage facilities by the US – FDA, Darmstadt – Germany, TGA Australia, MCC-South Africa and UK – MHRA, Indoco has emerged as the most suitable partner and provider of Contract Research and Manufacturing Services (CRAMS) to its customers globally. 


Recently, Goa Plant II of Indoco Remedies which is located at Verna Industrial Estate, has received Good Manufacturing Practice (GMP) Compliance certificate from the State Institute for Drug Control (SUKL), Czech Republic. The plant has been inspected in connection with marketing authorization(s) listing manufacturer, located outside of the European Economic Area in accordance with Art. 111(4) of the Directive 2001/83/EC transposed in the following national legislation: Section 101 paragraph 3 of Act No. 378/2007 COIL., on Pharmaceuticals and on Amendment to Some Reined Acts (the Act of Pharmaceuticals) as amended. 

The GMP compliance certificate is related to manufacture of sterile ophthalmic formulations. This certificate proves that the sterile opthalmic formulations manufactured in this plant are in GMP compliance and fulfills the GMP recommendations of World Health Organisation (WHO). 

The Pharma Times News Bureau

Recent Posts

World Diabetes Day Survey: Diabetologists and Endocrinologists demand for AI-Based Training and Upskilling in Diabetes Care

 A striking 90% of the 3000 Diabetologists and Endocrinologists surveyed, emphasised the importance of continuous…

19 hours ago

Doctors warn diabetes patients about risk of smoking

People who smoke are also at much higher risk of developing diabetes compared to non-smokers…

2 days ago

CPHI & PMEC India Expo: Encouraging affordable solutions in India’s march towards a $130 Billion Pharma Market by 2030

17th edition of CPHI& PMEC India Expo to be held from 26th November-28thNovember 2024, at the India…

2 days ago

Sringeri Sharada Equitas Hospital Revolutionizing Cancer Care with the Launch of Low-cost, High Quality Radiation Therapy

The launch signifies Equitas’ redefined commitment to bring world-class cancer radiation therapy accessible to all.…

3 days ago